The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma is a research paper published in Journal of Personalized Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01CA247497
NIH
Grant: U01CA239258
Lymphoma Research Foundation
Grant: Career Development Award
FWCI
0.93
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals